Skip to main navigation

Oral Delivery of Large Molecules

Oral Delivery of Large Molecules

Investor Relations

  • Home
  • About Us
    • Company Profile
    • Strategy
    • Management Team
    • Board of Directors
  • Technology
    • Oral Drug Delivery
    • Parathyroid Hormone
      • Supportive Publications
      • Hypoparathyroidism Market
  • Pipeline
    • Progress Summary
    • Hypoparathyroidism
    • Osteoporosis
    • Bone Healing
  • News and Events
    • News
    • Events
  • Investors
    • Share Information
      • Share Chart
    • Email Alerts
    • Press Releases
    • SEC Filings
    • Investor Calendar
    • Corporate Governance
      • Board of Directors
      • Management
      • Committee Composition
    • Investor Resources
      • Document Request
      • Email alerts
      • Investor FAQS
    • Investor Presentation

Oral Delivery of Large Molecules

Investor

Overview

SEC Filing Details

Document Details

Form
UPLOAD
Filing Date
Oct 5, 2017
Document Date
Oct 5, 2017
Form Description
UPLOAD
Filing Group
Other
Company
Entera Bio Ltd.
Issuer
Entera Bio Ltd.

Filing Formats

Download PDF

Sidebar

  • Investor Presentation
  • Share Information
    • Share Chart
  • Press Releases
  • SEC Filings
  • Investor Calendar
  • Corporate Governance
    • Board of Directors
    • Management
    • Committee Composition
  • Investor Resources
    • Investor FAQs
    • Document Request
    • Email Alerts
Enterabio logo

Kiryat Hadassah
Minrav Building, 5th Floor
Po Box 12117
Jerusalem 91220 Israel
Email Investor Relations
 

About Us

  • Company Profile
  • Strategy
  • Management Team
  • Board of Directors

Technology

  • Overview

Pipeline

  • Progress Summary
  • Hypoparathyroidism
  • Osteoporosis
  • Bone Healing

News and Events

  • News
  • Events

Footer Menu

  • Home
  • Sitemap
©2022 Entera Bio Ltd.